Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Pharmacotherapy of heart failure in the elderly: Adverse events
Michael W. Rich
Division of Cardiology
Institute of Clinical and Translational Sciences (ICTS)
COVID-19 Researchers
Research output
:
Contribution to journal
›
Review article
›
peer-review
34
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacotherapy of heart failure in the elderly: Adverse events'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Events
100%
Older Patients
100%
Heart Failure
100%
Heart Failure Patients
100%
Pharmacotherapy
100%
Heart Failure Therapy
100%
Clinically Significant
50%
Risk Reduction
50%
Body Composition
50%
Aging
50%
Metabolism
50%
Impaired Quality of Life
50%
Patients with Heart Failure
50%
Organ Function
50%
Medical Conditions
50%
Drug Interactions
50%
Adverse Drug Events
50%
Close Follow-up
50%
Substantial Change
50%
Absorption Distribution
50%
Human Organs
50%
Effect Interaction
50%
Judicious Use
50%
Medication Dosage
50%
Composition Function
50%
Adverse Drug Effects
50%
Unnecessary Medication
50%
Medicine and Dentistry
Drug Therapy
100%
Adverse Event
100%
Congestive Heart Failure
100%
Adverse Drug Reaction
33%
Clinician
16%
Quality of Life
16%
Side Effect
16%
Drug Interaction
16%
Nursing and Health Professions
Adverse Event
100%
Drug Therapy
100%
Congestive Heart Failure
100%
Adverse Drug Reaction
33%
Practice Guideline
16%
Quality of Life
16%
Body Composition
16%
Side Effect
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Congestive Heart Failure
100%
Pharmacotherapy
100%
Adverse Drug Reaction
33%
Side Effect
16%
Elimination
16%
Drug Interaction
16%